About Payerpath
Payerpath is a company based in Richmond (United States) founded in 1998 was acquired by Allscripts in June 2006. Payerpath has raised $6.2 million across 1 funding round from investors including Finastra, Acacia Venture Partners and Salix Ventures. Payerpath operates in a competitive market with competitors including iMedX, Xifin, Infinx, AKASA and R1 RCM, among others.
- Headquarter Richmond, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.2 M (USD)
in 1 rounds
-
Latest Funding Round
$6.2 M (USD), Series A
Mar 02, 2000
-
Investors
Finastra
& 3 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Payerpath
Payerpath has successfully raised a total of $6.2M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.2 million completed in March 2000. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Payerpath
Payerpath has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Finastra, Acacia Venture Partners and Salix Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Offers healthcare data analytics, tech platforms, and networks for providers and payers.
|
Locked | Locked | Locked |
Investor details for Payerpath
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Payerpath
Investment portfolio details for Payerpath
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Payerpath
Detailed financials for Payerpath
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Payerpath Comparisons
Peer comparison for Payerpath
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Payerpath
Payerpath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iMedX, Xifin, Infinx, AKASA and R1 RCM, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Revenue cycle management platform is provided to healthcare providers.
|
|
| Locked | Locked | Locked |
Cloud-based billing & revenue cycle management solutions for diagnostic service providers
|
|
| Locked | Locked | Locked |
Revenue cycle management platform for healthcare is provided.
|
|
| Locked | Locked | Locked |
Revenue cycle automation platforms are provided for healthcare reimbursement.
|
|
| Locked | Locked | Locked |
End-to-end revenue cycle management is provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Billing solutions for dentists are provided by Zentist.
|
Detailed competitors of Payerpath
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Payerpath
Complete news archive for Payerpath
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Payerpath
Payerpath was founded in 1998 and raised its 1st funding round 2 years after it was founded.
Payerpath is headquartered in Richmond, United States. It is registered at Richmond, Virginia, United States.
Payerpath is a funded company, having raised a total of $6.2M across 1 funding round to date.
Founded in 1998 and based in Richmond, United States, Payerpath operates in the healthcare sector by delivering web-based revenue cycle management software and services to providers and payers. Claims processing, electronic medical claim systems, billing and coding applications, and insurance claim handling are included among its offerings. Funding of 6.2 million was secured in 2000 from investors such as Marquette Venture Partners. Acquisition by Allscripts Healthcare Solutions occurred in 2006.
Payerpath's top competitors include R1 RCM, AKASA and ABI Health.
Payerpath has 4 investors. Key investors include Finastra, Acacia Venture Partners, Salix Ventures, and Allscripts.